Top

Archives of Osteoporosis

Published in:

Open Access 01-12-2023 | Osteoporosis | Original Article

Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan

Authors: Tomoko Fujii, Takahiro Mori, Jun Komiyama, Naoaki Kuroda, Nanako Tamiya

Published in: Archives of Osteoporosis | Issue 1/2023

Abstract

Summary

In an analysis of claims data from a city in Japan, male patients and patients with dementia were less likely to receive osteoporosis pharmacotherapy after hip fracture. Treatment initiation rate has improved between 2014 and 2017.

Purpose

Older adults with recent hip fractures are at a high risk of recurrent fractures. However, the post-fracture care gap has been reported globally. This study examines factors associated with pharmacotherapy non-initiation within 1 year after hip surgery.

Methods

Using medical and long-term care (LTC) claims, and LTC needs certification data in Tsukuba City, Japan, we identified individuals aged 65 years or older who had hip fractures with subsequent surgical procedures between October 1, 2014, and December 31, 2017. Patient (age, sex, dementia, and comorbidities) and health service–related characteristics (fiscal year, type of hospital, number of hospital beds, and admission to recovery phase rehabilitation wards) were examined. The association of these factors with non-pharmacotherapy for osteoporosis within 1 year after hip fracture using multivariable logistic models was analyzed.

Results

We identified 275 patients with hip fractures who did not receive pharmacotherapy pre-fracture. Forty percent of them received pharmacotherapy within 1 year of post-fracture. Male sex (odds ratio (OR) = 4.49 [2.14–9.44]) and dementia (OR = 1.90 [1.03–3.52]) were associated with no pharmacotherapy, whereas later fiscal year (OR = 0.64 [0.48–0.87]) and admission to rehabilitation wards (OR = 0.25 [0.14–0.46]) were associated with pharmacotherapy initiation within 1 year of post-fracture. Comorbidities were not associated with the initiation of pharmacotherapy.

Conclusion

Pharmacotherapy for osteoporosis was less likely to be initiated after a hip fracture in male patients and patients with dementia. These patients should be considered for pharmacotherapy because they are at high risk of recurrent fractures.

Available only for authorised users

Boonen S, Autier P, Barette M, Vanderschueren D, Lips P, Haentjens P (2004) Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int 15:87–94. https://doi.org/10.1007/s00198-003-1515-zCrossRefPubMed

Adachi JD, Loannidis G, Berger C et al (2001) The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12:903–908. https://doi.org/10.1007/s001980170017CrossRefPubMed

Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573–1579. https://doi.org/10.1001/jama.2009.1462CrossRefPubMedPubMedCentral

Katsoulis M, Benetou V, Karapetyan T et al (2017) Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med 281:300–310. https://doi.org/10.1111/joim.12586CrossRefPubMed

Mori T, Komiyama J, Fujii T et al (2022) Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database. Arch Osteoporos 17:61. https://doi.org/10.1007/s11657-022-01096-8CrossRefPubMedPubMedCentral

Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14–21. https://doi.org/10.1007/s00223-011-9545-6CrossRefPubMed

Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387–394. https://doi.org/10.1001/jama.297.4.387CrossRefPubMed

Peng J, Liu Y, Chen L, Peng K, Xu Z, Zhang D, Xiang Z (2016) Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: a meta-analysis. Pak J Med Sci 32:499–504. https://doi.org/10.12669/pjms.322.9435CrossRefPubMedPubMedCentral

Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929–1937. https://doi.org/10.1002/jbmr.2202CrossRefPubMed

10.

Kim SC, Kim MS, Sanfélix-Gimeno G et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128:519–26.e1. https://doi.org/10.1016/j.amjmed.2015.01.014CrossRefPubMedPubMedCentral

11.

Wilk A, Sajjan S, Modi A, Fan CP, Mavros P (2014) Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA. Osteoporos Int 25:2777–2786. https://doi.org/10.1007/s00198-014-2827-xCrossRefPubMedPubMedCentral

12.

Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2021) Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Arch Osteoporos 16:130. https://doi.org/10.1007/s11657-021-00992-9CrossRefPubMed

13.

Cheung MY, Ho AW, Wong SH (2018) Postfracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012. Hong Kong Med J 24:579–583. https://doi.org/10.12809/hkmj187227CrossRefPubMed

14.

Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM (2018) Association of osteoporosis medication use after hip fracture with prevention of subsequent nonvertebral fractures: an instrumental variable analysis. JAMA Netw Open 1:e180826. https://doi.org/10.1001/jamanetworkopen.2018.0826CrossRefPubMedPubMedCentral

15.

Kanahori M, Matsumoto Y, Fujiwara T et al (2021) Predictive factors of non-treatment and non-persistence to osteoporosis medication after fragility hip fractures at 3 years after discharge: a multicentre, prospective cohort study in the northern Kyushu district of Japan. Arch Osteoporos 16:132. https://doi.org/10.1007/s11657-021-00988-5CrossRefPubMed

16.

Beaton DE, Dyer S, Jiang D, Sujic R, Slater M, Sale JE, Bogoch ER, Osteoporosis Fracture Clinic Screening Program Evaluation Team (2014) Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program. Osteoporos Int 25:289–296. https://doi.org/10.1007/s00198-013-2430-6CrossRefPubMed

17.

Oyamada A, Matsumoto Y, Wakata Y et al (2018) Characteristics of patients with fragility hip fractures in the northern Kyushu district in Japan: a multicenter prospective registry based on an electronic data capture system. J Bone Miner Metab 36:596–604. https://doi.org/10.1007/s00774-017-0869-9CrossRefPubMed

18.

McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028–1034. https://doi.org/10.1007/s00198-003-1507-zCrossRefPubMed

19.

Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B, Eisman JA, Geusens PP, Brink PR (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96:e29. https://doi.org/10.2106/JBJS.L.00223CrossRefPubMed

20.

Wu CH, Tu ST, Chang YF, Chan DC, Chien JT, Lin CH, Singh S, Dasari M, Chen JF, Tsai KS (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92–100. https://doi.org/10.1016/j.bone.2018.03.018CrossRefPubMed

21.

Hagino H, Wada T (2019) Osteoporosis liaison service in Japan. Osteoporos Sarcopenia 5:65–68. https://doi.org/10.1016/j.afos.2019.09.003CrossRefPubMedPubMedCentral

22.

City of Tsukuba (2014). Statistics. https://www.city.tsukuba.lg.jp/shisei/joho/toukei/1002336.html. Accessed 31 Jul 2022

23.

Kuroda N, Iwagami M, Hamada S, Komiyama J, Mori T, Tamiya N (2022) Associations of polypharmacy and drugs with sedative or anticholinergic properties with the risk of long-term care needs certification among older adults in Japan: A population-based, nested case-control study. Geriatr Gerontol Int 22:497–504. https://doi.org/10.1111/ggi.14393CrossRefPubMed

24.

Hagino H, Endo N, Harada A, Iwamoto J, Mashiba T, Mori S, Ohtori S, Sakai A, Takada J, Yamamoto T (2017) Survey of hip fractures in Japan: recent trends in prevalence and treatment. J Orthop Sci 22:909–914. https://doi.org/10.1016/j.jos.2017.06.003CrossRefPubMed

25.

Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139. https://doi.org/10.1097/01.mlr.0000182534.19832.83CrossRefPubMed

26.

Mori T, Tamiya N, Jin X, Jeon B, Yoshie S, Iijima K, Ishizaki T (2018) Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan. Arch Osteoporos 13:37. https://doi.org/10.1007/s11657-018-0448-2CrossRefPubMedPubMedCentral

27.

Mori T, Hamada S, Yoshie S, Jeon B, Jin X, Takahashi H, Iijima K, Ishizaki T, Tamiya N (2019) The associations of multimorbidity with the sum of annual medical and long-term care expenditures in Japan. BMC Geriatr 19:69. https://doi.org/10.1186/s12877-019-1057-7CrossRefPubMedPubMedCentral

28.

Noda H, Yamagishi K, Ikeda A, Asada T, Iso H (2018) Identification of dementia using standard clinical assessments by primary care physicians in Japan. Geriatr Gerontol Int 18:738–744. https://doi.org/10.1111/ggi.13243CrossRefPubMed

29.

Kuroda N, Hamada S, Sakata N, Jeon B, Iijima K, Yoshie S, Ishizaki T, Jin X, Watanabe T, Tamiya N (2019) Antipsychotic use and related factors among people with dementia aged 75 years or older in Japan: a comprehensive population-based estimation using medical and long-term care data. Int J Geriatr Psychiatry 34:472–479. https://doi.org/10.1002/gps.5041CrossRefPubMed

30.

Japan Osteoporosis Society, the Japanese Society for Bone and Mineral Research, Japan Osteoporosis Foundation (2015) Japanese 2015 guidelines for prevention and treatment of osteoporosis (in Japanese). Life Science Publishing

31.

Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623–2637. https://doi.org/10.1007/s00198-018-4759-3CrossRefPubMed

32.

García-Sempere A, Hurtado I, Sanfélix-Genovés J, Rodríguez-Bernal CL, Gil Orozco R, Peiró S, Sanfélix-Gimeno G (2017) Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Sci Rep 7:11784. https://doi.org/10.1038/s41598-017-10899-6CrossRefPubMedPubMedCentral

33.

Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E (2010) Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiol (Camb Mass) 21:658–668. https://doi.org/10.1097/EDE.0b013e3181e89905CrossRef

34.

Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30:637–646. https://doi.org/10.1002/jbmr.2393CrossRefPubMed

35.

Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521. https://doi.org/10.1001/jama.2009.50CrossRefPubMed

36.

Nakatoh S, Fujimori K, Tamaki J, Okimoto N, Ogawa S, Iki M (2020) Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip fracture in Japan. J Bone Miner Metab 38:589–596. https://doi.org/10.1007/s00774-020-01093-2CrossRefPubMed

37.

Yong JH, Masucci L, Hoch JS, Sujic R, Beaton D (2016) Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision. Osteoporos Int 27:231–240. https://doi.org/10.1007/s00198-015-3280-1CrossRefPubMed

38.

Martin J, Viprey M, Castagne B, Barral M, Chapurlat R, Julien C, Serrier H, Schott AM (2020) Cost-effectiveness analyses of interventions to improve osteoporosis care in France. Arch Osteoporos 15:42. https://doi.org/10.1007/s11657-020-00720-9CrossRefPubMed

39.

Sugiyama T, Imai K, Ihana-Sugiyama N et al (2019) Variation in process quality measures of diabetes care by region and institution in Japan during 2015–2016: an observational study of nationwide claims data. Diabetes Res Clin Pract 155:107750. https://doi.org/10.1016/j.diabres.2019.05.029CrossRefPubMed

40.

Martin J, Viprey M, Castagne B, Merle B, Giroudon C, Chapurlat R, Schott AM (2020) Interventions to improve osteoporosis care: a systematic review and meta-analysis. Osteoporos Int 31:429–446. https://doi.org/10.1007/s00198-020-05308-0CrossRefPubMed

Title: Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan
Authors: Tomoko Fujii
Takahiro Mori
Jun Komiyama
Naoaki Kuroda
Nanako Tamiya
Publication date: 01-12-2023
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Dementia
Dementia
Care
Published in: Archives of Osteoporosis / Issue 1/2023
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-023-01314-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan

Abstract

Summary

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Risk factors predicting the ‘time to first fracture’ and its association with imminent fractures: a substudy of the FRISBEE cohort

Assessment of calcium intake and recognition of calcium-rich food sources among the Saudi population

Relationships between sclerostin and morphometric vertebral fractures, bone mineral density, and bone microarchitecture in postmenopausal women

Correction to: Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study

Not only muscle mass but also muscle quality is associated with knee extension muscle strength in patients with hip fractures

Adipopenia is associated with osteoporosis in community-dwelling non-underweight adults independent of sarcopenia